IDEX Biometrics ASA
IDXAF
$0.89
$0.69345.00%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 180.60K | 69.00K | -- | 81.00K | 100.30K |
| Total Other Revenue | -- | -- | -- | -- | 100.00 |
| Total Revenue | 180.60K | 69.00K | -- | 81.00K | 100.40K |
| Cost of Revenue | 76.20K | 461.00K | 8.00K | 57.00K | 83.00K |
| Gross Profit | 104.40K | -392.00K | -8.00K | 24.00K | 17.30K |
| SG&A Expenses | 1.21M | 566.00K | 515.00K | 679.00K | 858.20K |
| Depreciation & Amortization | 36.10K | 69.00K | 132.00K | 140.00K | 133.20K |
| Other Operating Expenses | 1.07M | 1.03M | 975.00K | 1.72M | 1.52M |
| Total Operating Expenses | 2.70M | 2.06M | 1.98M | 3.13M | 3.10M |
| Operating Income | -2.52M | -1.99M | -1.98M | -3.05M | -3.00M |
| Income Before Tax | -3.95M | -2.80M | -992.00K | -2.11M | -3.99M |
| Income Tax Expenses | -- | 0.00 | -- | -43.00K | 2.40K |
| Earnings from Continuing Operations | -3.95M | -2.80M | -992.00K | -2.07M | -3.99M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.95M | -2.80M | -992.00K | -2.07M | -3.99M |
| EBIT | -2.52M | -1.99M | -1.98M | -3.05M | -3.00M |
| EBITDA | -2.48M | -1.59M | -1.85M | -2.91M | -2.87M |
| EPS Basic | -0.06 | -0.06 | -0.02 | -0.07 | 0.00 |
| Normalized Basic EPS | -0.04 | 0.00 | -0.01 | -0.04 | 0.00 |
| EPS Diluted | -0.06 | -0.06 | -0.02 | -0.07 | 0.00 |
| Normalized Diluted EPS | -0.04 | 0.00 | -0.01 | -0.04 | 0.00 |
| Average Basic Shares Outstanding | 64.19M | 47.28M | 42.11M | 29.88M | 883.78M |
| Average Diluted Shares Outstanding | 64.19M | 47.28M | 42.11M | 29.88M | 883.78M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |